Search for: "Eli Lilly " Results 781 - 800 of 2,131
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jul 2014, 10:31 pm
Takeda is to be responsible for $6 billion of the punitive award and Eli Lilly, which marketed the drug, would be responsible for the remaining $3 billion. [read post]
6 Aug 2014, 6:42 am by Michael Geist
Analysis without the text is difficult, however, the combination of prior leaks and media reports indicate that Canada caved on its concerns regarding the potential replication of Eli Lilly-style pharmaceutical patent lawsuits. [read post]
6 Jul 2016, 1:40 pm by Tom Lamb
PDE-5 inhibitors: Adcirca (tadalafil; Eli Lilly and Company): tablets Cialis (tadalafil; Eli Lilly and Company): tablets Levitra (vardenafil hydrochloride; GlaxoSmithKline): orally disintegrating tablets Revatio (sildenafil citrate; Pfizer): tablets, oral suspension, and injection Staxyn (vardenafil hydrochloride; GlaxoSmithKline): orally disintegrating tablets Stendra (avanafil; Vivus and Auxilium Pharmaceuticals): tablets Viagra (sildenafil citrate; Pfizer):… [read post]
12 Feb 2016, 7:59 pm
 Their product, for the foreseeable future, will not infringe Eli Lilly's patent. [read post]
23 Dec 2015, 7:24 pm
” So with that, Mr Justice Carr held the Patent valid and Lilly’s counterclaim for threatened infringement succeeded.Conclusion The plausib [read post]
18 Feb 2021, 10:24 am by Lisa Larrimore Ouellette
The public information about manufacturing Regeneron’s and Eli Lilly’s cocktails is limited. [read post]
17 Jul 2011, 9:55 am by Hugh Tomlinson QC, Matrix Law
There are two appeals in the Supreme Court beginning with Human Genome Sciences Inc v Eli Lilly and Company to be heard on Monday 18 to Wednesday 20 July 2011 by Lords Hope, Walker, Neuberger, Collins and Clarke. [read post]
4 Jun 2020, 2:58 am by Dennis Crouch
Eli Lilly and Company, No. 19-1058; Dr. [read post]
15 Jul 2017, 5:11 am
The summary stated that the Supreme Court allows Eli Lilly's appeal and holds that Actavis' products directly infringe Eli Lilly's patent in the United Kingdom, France, Italy and Spain. [read post]
9 Jul 2012, 4:34 am by Max Kennerly, Esq.
Remember how, three years ago, Pfizer paid $2.3 billion to the Department of Justice to settle off-label claims relating to Bextra and other drugs, and Eli Lilly paid $1.4 billion for Zyprexa marketing? [read post]
4 Dec 2019, 7:57 am by Brian Cordery
Brian Corderyby Selina Badiani The leading Supreme Court case of Actavis v Eli Lilly [2017] UKSC 48 introduced a doctrine of equivalents into UK patent law for the first time in many years. [read post]
15 Jul 2009, 12:00 am
  Of course, this approach has long been used by plaintiffs' lawyers, but it is now becoming more common for the defense.For example, Duane Morris billed on a contingency basis when it defended Eli Lilly in a $1.4 billion whistle blower suit over allegations of improper marketing of an anti-psychotic drug. [read post]
19 Oct 2014, 5:27 am
Increasingly, the measures under scrutiny involve IP rights: Philip Morris currently challenges tobacco packaging rules in Australiaand Uruguayas a form of indirect expropriation; while the US pharmaceutical company Ely Lilly is suing Canadaunder NAFTA’s investment protection rules for the revocation of two crucial patents (for its drugs Zyprexa and Strattera) by Canadian courts.A confident Gustav pictured moments afterbeing asked to explain the internationalinvestment… [read post]